FMC Corporation board elects Dr. Bénédicte Flambard as vice president, Plant Health
FMC Corporation has appointed Dr. Bénédicte Flambard as vice president, joining the senior management Operating Committee while continuing to lead the Plant Health business. Under her leadership, the Plant Health division has significantly expanded, launching new biological products like Accudo® and Nema-C®, and acquiring BioPhero ApS. FMC is focusing on enhancing its position in the biologicals sector, which is a fast-growing segment of the company. Flambard will operate from FMC's European Innovation Center in Denmark.
- Appointment of Dr. Bénédicte Flambard as vice president, indicating strategic leadership.
- Significant growth in the Plant Health division under Flambard's leadership.
- Successful launch of new biological products, enhancing FMC's market position.
- Acquisition of BioPhero ApS, expanding FMC's capabilities in pheromone research.
- None.
PHILADELPHIA, Oct. 24, 2022 /PRNewswire/ --
FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, has elected Dr. Bénédicte Flambard an FMC vice president. She will join the company's senior management Operating Committee and will continue to lead FMC's Plant Health business reporting to Ronaldo Pereira, executive vice president, president of FMC Americas.
"Bénédicte's extensive technical knowledge and business acumen in biologicals have helped accelerate the growth and expansion of FMC's Plant Health business," said Mark Douglas, president and CEO. "During her three years leading this business, FMC Plant Health has grown substantially, has launched several new biological products, and has strengthened our award-winning discovery research and development pipelines with new biological solutions."
Flambard will continue to be based at FMC's European Innovation Center in Denmark, the company's global Plant Health headquarters and primary laboratories for biologicals research.
"Under Bénédicte's leadership, we have invested significantly to expand FMC Plant Health, especially in biologicals," said Pereira. "In the last few years, we have launched Accudo® biostimulant, Nema-C® bionematicide, Ataplan™ biofungicide and recently Provilar™ foliar biofungicide, which are all performing well in their launch markets; entered into a co-development agreement with Novozymes; and launched our new sub-brand, 'Biologicals by FMC.' Bénédicte also helped lead our recent acquisition of BioPhero ApS, the leading pheromone research and production company that pioneered a highly efficient yeast fermentation process." Pereira added, "She has been a driving force behind our strong biologicals performance, and I know she will continue to build FMC's leadership position in one of the fastest growing segments of our company."
Prior to joining FMC in 2019, Flambard held a variety of research and commercial leadership roles of increasing responsibility at biotherapeutics, nutraceuticals and microbial science companies throughout Europe.
About FMC
FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers, crop advisers and turf and pest management professionals to address their toughest challenges economically while protecting the environment. With approximately 6,400 employees at more than 100 sites worldwide, FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn® and Twitter®.
Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. FMC, the FMC logo, Accudo®, Nema-C®, Ataplan™ and Provilar™ are trademarks of FMC Corporation or an affiliate.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements, which are based on management's current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These factors include, among other things, the risk factors and other cautionary statements included within FMC's 2021 Form 10-K filed with the SEC as well as other SEC filings and public communications. FMC cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement. FMC undertakes no obligation, and specifically disclaims any duty, to update or revise any forward-looking statements to reflect events or circumstances arising after the date on which they were made, except as otherwise required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporation-board-elects-dr-benedicte-flambard-as-vice-president-plant-health-301657674.html
SOURCE FMC Corporation
